Prelude Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $10k | 6.9k | 1.44 |
| 2025-06-30 | $14k | 17k | 0.81 |
| 2025-03-31 | $10k | 14k | 0.77 |
| 2024-12-31 | $13k | 10k | 1.28 |
| 2024-09-30 | $11k | 5.3k | 2.07 |
| 2024-06-30 | $27k | 7.1k | 3.81 |
| 2024-03-31 | $16k | 3.3k | 4.74 |
| 2023-09-30 | $11k | 3.5k | 3.00 |
| 2023-06-30 | $9.4k | 2.1k | 4.50 |
| 2023-03-31 | $77k | 13k | 5.78 |
| 2022-12-31 | $20k | 3.5k | 5.58 |
| 2022-09-30 | $9.1k | 1.3k | 7.25 |
| 2022-06-30 | $21k | 4.0k | 5.16 |
| 2022-03-31 | $25k | 2.3k | 10.87 |
| 2021-12-31 | $65k | 5.3k | 12.24 |
| 2021-09-30 | $109k | 3.5k | 31.07 |
| 2021-06-30 | $31k | 1.1k | 28.71 |
| 2021-03-31 | $122k | 2.8k | 43.49 |
| 2020-12-31 | $15k | 205 | 73.17 |